πŸ‡ΊπŸ‡Έ FDA
Patent

US 6962996

Inhibitors of p38

expired A61PA61P1/00A61P1/04

Quick answer

US patent 6962996 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18